314 related articles for article (PubMed ID: 10654153)
41. Retrieval and classification of dental research articles.
Bartling WC; Schleyer TK; Visweswaran S
Adv Dent Res; 2003 Dec; 17():115-20. PubMed ID: 15126221
[TBL] [Abstract][Full Text] [Related]
42. Correlation between the Uptake of 18F-Fluorodeoxyglucose (18F-FDG) and the Expression of Proliferation-Associated Antigen Ki-67 in Cancer Patients: A Meta-Analysis.
Deng SM; Zhang W; Zhang B; Chen YY; Li JH; Wu YW
PLoS One; 2015; 10(6):e0129028. PubMed ID: 26038827
[TBL] [Abstract][Full Text] [Related]
43. F18-FDG-PET for recurrent differentiated thyroid cancer: a systematic meta-analysis.
Haslerud T; Brauckhoff K; Reisæter L; Küfner Lein R; Heinecke A; Varhaug JE; Biermann M
Acta Radiol; 2016 Oct; 57(10):1193-200. PubMed ID: 26163534
[TBL] [Abstract][Full Text] [Related]
44. End-therapy positron emission tomography for treatment response assessment in follicular lymphoma: a systematic review and meta-analysis.
Pyo J; Won Kim K; Jacene HA; Sakellis CG; Brown JR; Van den Abbeele AD
Clin Cancer Res; 2013 Dec; 19(23):6566-77. PubMed ID: 24052020
[TBL] [Abstract][Full Text] [Related]
45. Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy--systematic review.
Westerterp M; van Westreenen HL; Reitsma JB; Hoekstra OS; Stoker J; Fockens P; Jager PL; Van Eck-Smit BL; Plukker JT; van Lanschot JJ; Sloof GW
Radiology; 2005 Sep; 236(3):841-51. PubMed ID: 16118165
[TBL] [Abstract][Full Text] [Related]
46. A review of the literature for whole-body FDG PET in the management of patients with melanoma.
Schwimmer J; Essner R; Patel A; Jahan SA; Shepherd JE; Park K; Phelps ME; Czernin J; Gambhir SS
Q J Nucl Med; 2000 Jun; 44(2):153-67. PubMed ID: 10967625
[TBL] [Abstract][Full Text] [Related]
47. Preoperative assessment of cervical lymph nodes in head and neck cancer with fluorine-18 fluorodeoxyglucose using a dual-head coincidence camera: a pilot study.
Stokkel MP; ten Broek FW; van Rijk PP
Eur J Nucl Med; 1999 May; 26(5):499-503. PubMed ID: 10382094
[TBL] [Abstract][Full Text] [Related]
48. FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, "Onko-PET III", 21 July and 19 September 2000.
Reske SN; Kotzerke J
Eur J Nucl Med; 2001 Nov; 28(11):1707-23. PubMed ID: 11702115
[TBL] [Abstract][Full Text] [Related]
49. [Computerized tomography and F-18-FDG positron emission tomography in staging of malignant lymphomas: a comparison].
Bumann D; de Wit M; Beyer W; Beese M; Lübeck M; Bücheler E; Clausen M
Rofo; 1998 May; 168(5):457-65. PubMed ID: 9617362
[TBL] [Abstract][Full Text] [Related]
50. Brain
Bordonne M; Chawki MB; Doyen M; Kas A; Guedj E; Tyvaert L; Verger A
Eur J Nucl Med Mol Imaging; 2021 Nov; 48(12):3847-3858. PubMed ID: 33677643
[TBL] [Abstract][Full Text] [Related]
51. The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography.
Stokkel MP; Terhaard CH; Hordijk GJ; van Rijk PP
Eur J Nucl Med; 1999 Jul; 26(7):767-73. PubMed ID: 10398825
[TBL] [Abstract][Full Text] [Related]
52. Fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography in monitoring the response of breast cancer to neoadjuvant chemotherapy: a meta-analysis.
Mghanga FP; Lan X; Bakari KH; Li C; Zhang Y
Clin Breast Cancer; 2013 Aug; 13(4):271-9. PubMed ID: 23714689
[TBL] [Abstract][Full Text] [Related]
53. Dual modality of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in patients with cervical carcinoma of unknown primary.
Freudenberg LS; Fischer M; Antoch G; Jentzen W; Gutzeit A; Rosenbaum SJ; Bockisch A; Egelhof T
Med Princ Pract; 2005; 14(3):155-60. PubMed ID: 15863988
[TBL] [Abstract][Full Text] [Related]
54. F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging.
Gallowitsch HJ; Kresnik E; Gasser J; Kumnig G; Igerc I; Mikosch P; Lind P
Invest Radiol; 2003 May; 38(5):250-6. PubMed ID: 12750613
[TBL] [Abstract][Full Text] [Related]
55. Precision and recall of search strategies for identifying studies on return-to-work in Medline.
Gehanno JF; Rollin L; Le Jean T; Louvel A; Darmoni S; Shaw W
J Occup Rehabil; 2009 Sep; 19(3):223-30. PubMed ID: 19381789
[TBL] [Abstract][Full Text] [Related]
56. (18)F-FDG PET-CT: a powerful tool for the diagnosis and treatment of relapsing polychondritis.
Lei W; Zeng H; Zeng DX; Zhang B; Zhu YH; Jiang JH; Huang JA
Br J Radiol; 2016; 89(1057):20150695. PubMed ID: 26529231
[TBL] [Abstract][Full Text] [Related]
57. Comparison of search strategies for recalling double-blind trials from MEDLINE.
Gøtzsche PC; Lange B
Dan Med Bull; 1991 Dec; 38(6):476-8. PubMed ID: 1802637
[TBL] [Abstract][Full Text] [Related]
58. Searching the right database. A comparison of four databases for psychiatry journals.
McDonald S; Taylor L; Adams C
Health Libr Rev; 1999 Sep; 16(3):151-6. PubMed ID: 10620849
[TBL] [Abstract][Full Text] [Related]
59. Diagnostic Value of (18)F-FDG PET/CT in Detecting Local Recurrent Colorectal Cancer: A Pooled Analysis of 26 Individual Studies.
Yu T; Meng N; Chi D; Zhao Y; Wang K; Luo Y
Cell Biochem Biophys; 2015 Jun; 72(2):443-51. PubMed ID: 25737131
[TBL] [Abstract][Full Text] [Related]
60. Emerging role of whole-body 18F-fluorodeoxyglucose positron emission tomography as a marker of disease activity in patients with sarcoidosis: a systematic review.
Treglia G; Taralli S; Giordano A
Sarcoidosis Vasc Diffuse Lung Dis; 2011 Oct; 28(2):87-94. PubMed ID: 22117499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
